327 related articles for article (PubMed ID: 22067612)
1. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults.
Jones ML; Martoni CJ; Parent M; Prakash S
Br J Nutr; 2012 May; 107(10):1505-13. PubMed ID: 22067612
[TBL] [Abstract][Full Text] [Related]
2. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.
Jones ML; Martoni CJ; Prakash S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2944-51. PubMed ID: 23609838
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial.
Jones ML; Martoni CJ; Prakash S
Eur J Clin Nutr; 2012 Nov; 66(11):1234-41. PubMed ID: 22990854
[TBL] [Abstract][Full Text] [Related]
4. Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242.
Martoni CJ; Labbé A; Ganopolsky JG; Prakash S; Jones ML
Gut Microbes; 2015; 6(1):57-65. PubMed ID: 25612224
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study.
Jones ML; Martoni CJ; Tamber S; Parent M; Prakash S
Food Chem Toxicol; 2012 Jun; 50(6):2216-23. PubMed ID: 22425689
[TBL] [Abstract][Full Text] [Related]
6. Effects of yoghurt enriched with free plant sterols on the levels of serum lipids and plant sterols in moderately hypercholesterolaemic subjects on a high-fat diet.
Niittynen LH; Jauhiainen TA; Poussa TA; Korpela R
Int J Food Sci Nutr; 2008 Aug; 59(5):357-67. PubMed ID: 18979616
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: a randomized control trial.
Jones ML; Martoni CJ; Di Pietro E; Simon RR; Prakash S
Regul Toxicol Pharmacol; 2012 Jul; 63(2):313-20. PubMed ID: 22561556
[TBL] [Abstract][Full Text] [Related]
8. Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters.
Bhathena J; Martoni C; Kulamarva A; Urbanska AM; Malhotra M; Prakash S
J Med Food; 2009 Apr; 12(2):310-9. PubMed ID: 19459731
[TBL] [Abstract][Full Text] [Related]
9. Hypocholesterolemic effects of Lactobacillus reuteri LR6 in rats fed on high-cholesterol diet.
Singh TP; Malik RK; Katkamwar SG; Kaur G
Int J Food Sci Nutr; 2015 Feb; 66(1):71-5. PubMed ID: 25265203
[TBL] [Abstract][Full Text] [Related]
10. Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB 30242 capsules: a post-hoc analysis of a randomized controlled trial.
Jones ML; Martoni CJ; Ganopolsky JG; Sulemankhil I; Ghali P; Prakash S
Expert Opin Biol Ther; 2013 Dec; 13(12):1643-51. PubMed ID: 24074303
[TBL] [Abstract][Full Text] [Related]
11. Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects.
Noakes M; Clifton PM; Doornbos AM; Trautwein EA
Eur J Nutr; 2005 Jun; 44(4):214-22. PubMed ID: 15316827
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation.
Tomaro-Duchesneau C; Jones ML; Shah D; Jain P; Saha S; Prakash S
Biomed Res Int; 2014; 2014():380316. PubMed ID: 25295259
[TBL] [Abstract][Full Text] [Related]
13. Microencapsulated bile salt hydrolase producing Lactobacillus reuteri for oral targeted delivery in the gastrointestinal tract.
Martoni C; Bhathena J; Urbanska AM; Prakash S
Appl Microbiol Biotechnol; 2008 Nov; 81(2):225-33. PubMed ID: 18719901
[TBL] [Abstract][Full Text] [Related]
14. Limosilactobacillus reuteri consumption significantly reduces the total cholesterol concentration without affecting other cardiovascular disease risk factors in adults: A systematic review and meta-analysis.
Liu J; Zhu R; Song J; Sohaib M; Wang S; Mao J; Qi J; Xiong X; Zhou W; Guo L
Nutr Res; 2023 Sep; 117():1-14. PubMed ID: 37419064
[TBL] [Abstract][Full Text] [Related]
15. Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans.
Padro T; Santisteban V; Huedo P; Puntes M; Aguiló M; Espadaler-Mazo J; Badimon L
Cardiovasc Res; 2024 May; 120(7):708-722. PubMed ID: 38525555
[TBL] [Abstract][Full Text] [Related]
16. Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial.
Ferguson JJA; Stojanovski E; MacDonald-Wicks L; Garg ML
Metabolism; 2018 May; 82():22-35. PubMed ID: 29291429
[TBL] [Abstract][Full Text] [Related]
17. Design of a novel gut bacterial adhesion model for probiotic applications.
Rodes L; Coussa-Charley M; Marinescu D; Paul A; Fakhoury M; Abbasi S; Khan A; Tomaro-Duchesneau C; Prakash S
Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):116-24. PubMed ID: 22889228
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults.
Fuentes MC; Lajo T; Carrión JM; Cuñé J
Br J Nutr; 2013 May; 109(10):1866-72. PubMed ID: 23017585
[TBL] [Abstract][Full Text] [Related]
19. Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects.
Doornbos AM; Meynen EM; Duchateau GS; van der Knaap HC; Trautwein EA
Eur J Clin Nutr; 2006 Mar; 60(3):325-33. PubMed ID: 16234829
[TBL] [Abstract][Full Text] [Related]
20. An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults.
Costabile A; Buttarazzi I; Kolida S; Quercia S; Baldini J; Swann JR; Brigidi P; Gibson GR
PLoS One; 2017; 12(12):e0187964. PubMed ID: 29228000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
